Treatment of multiple sclerosis by oral administration of bovine

Details Treatment of multiple sclerosis by oral administration of bovine Treatment of multiple sclerosis by oral administration of bovine

1993-08-10

1998-12-15

Feisee, Lila

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

514 2, 514 8, 514 21, 530300, 530350, 530395, A61K 3900

Patent

active

058492984

ABSTRACT:
The invention is directed to a method of treating multiple sclerosis in animals, including humans, by the oral administration of bovine myelin.

REFERENCES:
Yoon, C.K., "MS Study Yields Mixed Results," Science 259:1263, 26 Feb. 1993.
Allegretta, M., et al., Science 247:718, 1990.
Al-Sabbagh, A., et al., Neurology 42(S3):346, 1992.
Campbell, B. et al., Arch. Neurol. 29:10, 1973.
Eylar, E. H. et al., Adv. Exp. Med. Biol. 98:259, 1978.
Gonsette, R. E. et al., J. Neurol. 216:27, 1977.
Higgins, P. J. et al., J. Neuroimmunol. 16:77, 1987.
Holoshitz, J. et al., J. Immunol. 131:2810, 1983.
Kardys, E. et al., J. Immunol. 127:862, 1981.
Khoury, S.J. et al., J. Exp. Med. 176:1355, 1992.
Miller, A. et al., J. Neuroimmunol. 39:243, 1992.
Miller, A. et al. Proc. Natl. Acad. Sci. USA 89:421, 1992.
Miller, A. et al. J. Immunol. 151:7307, 1993.
Mokhtarian, F. et al., Nature 309:356, 1984.
Mowat, A. M., Immunol. Today 8:93, 1987.
Richman, L.K. et al., J. Immunol. 121:2429, 1978.
Santos, L.M.B. et al., J., Immunol. 150: 115A 1993( abstact).
Weiner, H. L., et al., Science 259:1321 1993.
Whitacre, C.C. et al., Titles of Workshop Presentations, No. 615-09, 5th Int'l. Congr. of Immunol., Kyoto, Japan, 1983.
Whitacre, C.C. et al., J. Immunol. 147:2155 1991.
Higgins et al., J. Immunology, 140;440-445, 1988.
Eylar, Adv. Exp. Med. Bio., 98:259-281, 1978.
Sriram et al., Cell. Immunol., 75:378-382, 1983.
Nagler-Anderson et al., PNAS, 83:7443-7446, 1986.
Schoen, J. Immunol., 128:717-719, 1982.
Higgins et al., Annals Neurology, abstract No. P154, 1986.
Whitacre et al., 6th Int'l. Cong. Immunol., abstract No. 3.62.21, 1986.
Zamvil et al., Nature, 324:258-260, 1986.
Fritz et al., J. Immunol.,134;2328-2332, 1985.
Fritz et al., J. Immunol., 130:191-194, 1983.
Pettinelli et al., J. Immunol., 129:1209-1211, 1982.
Whitaker et al., J. Bio. Chem, 250:9106-9111, 1975.
Thompson et al., Clin. Exp. Immunol.,64:581-586, 1985.
Lider et al., J. Immunol., 142:748-752, 1989.
Friedman et al., PNAS, 91:6688-6692, 1994.
Bitar, dissertation entitled, The Suppressive Effects of Oral Myelin Basic Protein . . . , 1986.
Nagler-Anderson, dissertation entitled, Immunoregulation of an Exp. Model of Autoimmunity,1986.
Rothbart, 1st Forum in Virology, pp. 518-520, 1986.
Bitar et al., Cell. Immunol., 112:364-370, 1988.
Eylar et al., Neurochem. Research, 4:249-258, 1979.
Kagnoff, Oral Tolerance, pp. 248-269, 1982.
Mowat, Immunol. Today, 8:93-98, 1987.
Weiner et al., Science, 259:1321-1324, 1993.
Campbell et al, Arch. Neurol., 29:10-15, 1973.
Carnegie et al., Immunol. 19:55-63, 1970.
Fritz et al., J. Immunol., 130:1024-1026, 1983.
Hashim et al., Arch. Biochem. and Biophy., 156:287-297, 1973.
AutoImmune Press Release of Apr. 21, 1997.
Unanue et al., Science, 236:551-557 (1987).
Mattingly et al., Jour. of Immunol.,125:1044-1047 (1980).
Holoshitz et al., Science, 219:56-58 (1983).
Whitaker, Jour. of Biol. Chem., 250:9106-9111.
Miller, FASEB, 5:2560-2566.
Phadke et al., Arthritis and Rheumatism, 27(7):797-806 (1984).
Braley-Mullen et al., Cellular Immunology, 5:408-413 (1980).
Salk et al., Studies of Myelin Basic Protein Administration in Multiple Sclerosis Patients, 419-427 (1984).
Ngan et al., J. Immunol., 120:861 (1978).
Gautam et al., J. Immunol., 135:2975 (1985).
Titus et al., Int. Arch. Allergy Appl. Immunol., 65:323 (1981).
Nagler-Anderson et al., Proc. Nat'l. Acad. Sci. USA, 83:7443 (1986).
Swierkosz et al., J. Immunol.,119:1501 (1977).
Lando et al., Nature, 287:551 (1980).
Lando et al., J. Immunol, 126:1526 (1981).
Sriram et al., Cell. Immunol., 75:378 (1983).
Trauggot et al., J. Neurol. Sci., 56:65(1982).
Raine et al., Lab. Invest., 48:275 (1983).
McKenna et al., Cell. Immun., 81:391 (1983).
Sejan et al., Cell. Immun., 84:171 (1984).
McKenna et al., Cell. Immun., 88:251 (1984).
Burns et al., Neurology, 36:92 (1986).
Belik et al., Vopr. Med. Khim., 24:372 (1978).
Braley-Mullen al., Cell. Immun., 39:289 (1978).
McDermott et al., J. Neuro. Sci., 46:137 (1980).
Raziuddin et al., J. Immunol.,128:2073 (1982).
Eylar et al., Nature, 236:74 (1972).
Lider et al., J. Immunol., 142:748 (1989).
Michael, Immunol. Invest., 18:1049-1054 (1989).
Wells, J. Infect. Dis., 9:147 (1911).
Alvord et al., Annals of Neurol., 6:461 (1979).
Alford et al., Annals of Neurol., 6:469 (1979).
Alford et al., Annals of Neurol., 6:474 (1979).
Stoffel et al Proc Natl Acad sci USA vol. 81:5012, Sep. 1984.
Leitch, G.J. Proceeding Soc Exp Biology and Medicine vol. 121 (4) 1253-1256, Apr. 1966.

Affiliated with

Also associated with

Rating

Treatment of multiple sclerosis by oral administration of bovine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of multiple sclerosis by oral administration of bovine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of multiple sclerosis by oral administration of bovine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1455202